Researchers have been excited about Retatrutide , a groundbreaking dual agonist showing significant results in early trials for weight loss . It acts by targeting two hormones : GLP-1 and GIP, that , when activated , help control hunger and boost calorie burn. Preliminary observations demonstrate considerable body loss and potential benefits for pe